Come and solve scientific enigmas with PCB at CosmoCaixa! Blog Post

The «Live Research Fair», which will remain open at Cosmocaixa Barcelona until Saturday, 11 April, aims to bring science research closer to citizens, encourage dialogue between the public and researchers, encourage society´s scientific culture, and promote vocations among young people. The fair -organized annually by the Parc Científic of the Barcelona University under the «Research In Society» program, this year it is taking place with the support of Obra Social ”la Caixa” and the Ajuntament de Barcelona.

 

Avizorex Pharma announces Grant of U.S. Patent for its treatment of dry eye syndrome Blog Post

Avizorex Pharma, a biopharmaceutical company developing novel therapeutics for Dry Eye Disease, has announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for compositions and methods of treatment covering AVX-012, a topical treatment for Dry Eye Syndrome (DES) with a new mechanism of action currently undergoing late-stage preclinical studies. Avizorex Pharma is an ophthalmology biotech backed by Inveready Venture Capital with headquarters in Elche (Alicante, Spain) and offices at Barcelona Science Park (PCB).

 

The Parc Científic de Barcelona leads the Fair «Live Research Fair» at CosmoCaixa Blog Post

On the upcoming days of 8 9,10 and 11th of April, and as part of the 13th edition of the «Live Research Fair» , researchers from different research centres in Catalonia will be moving part of their laboratory setting to CosmoCaixa Barcelona to invite citizens to participate in their projects and solve puzzles following scientific methodology. The fair -organized annually by the Parc Científic de Barcelona under the “Research In Society” program – aims to bring science to society and promote scientific vocations among young people. This year, it is taking place with the support of “Obra Social ”la Caixa”  and the Ajuntament de Barcelona.

El PCB hosts the presentation of EIT Health Spain, the Spanish node of the most important European initiative in health innovation Blog Post

Parc Científic de Barcelona hosted yesterday the public presentation of the Spanish node of the Knowledge and Innovation Community (KIC) in Health or EIT-Health. Constituted by the European Institute of Technology (EIT), it is the most ambitious project ever carried out with public funds in Europe in the field of health innovation to foster healthy lifestyles and active ageing. With headquarters at PCB, EIT Health Spain –led by the University of Barcelona (UB) with the support of Biocat– is made up of 25 leading public and private organizations in their respective sectors and is committed to health innovation. 

 

 

iMols, the Mind the Byte cloud platform for drug discovery, is now available free of charge Blog Post

Mind the Byte –based at the Parc Científic de Barcelona and specializing in the provision of services and solutions for computational drug discovery- has opened cloud platform for use by the scientific, academic and business community. iMols is the first cloud platform specifically designed for drug discovery using the SaaS (‘Software as a Service’) approach. Mols is a SaaS platform breaks the two main barriers faced by computational drug design: implementation costs – it eliminates investments in servers and software licensing- and the training of the team, as it is an easy-to-use and intuitive tool requiring very little training.

 

Parc Científic de Barcelona takes part in the closing event of «Tastets de Ciència» Blog Post

As part of the «Escuelas Tándem» initiative that is being carried out jointly by the Apel·les Mestres school of L’Hospitalet de Llobregat, the Parc Científic de Barcelona (PCB) and the Aids Research Institute (IrsiCaixa) –with the support of Fundació Catalunya-La Pedrera– the closing event of the «Tastets de Ciència» was held on 23 January at the auditorium of the school. The event concluded with the presentation of diplomas to students who participated in this initiative and to students who worked as monitors in these series workshops entitled «Research in Primary Schools»  organised by the PCB.

Spark, a new public-private project created to develop a drug to fight the cognitive impairment associated with schizophrenia Blog Post

A public-private consortium led by the biotech Iproteos –based at the Barcelona Science Park–, and comprised by the biopharmaceutical company Ascil Biopharm, the Institute for Biomedical Research (IRB Barcelona), the Centre for Genomic Regulation (CRG) and the University of the Basque Country (UPV/EHU) has launched a project to advance the development of a new neuroprotective drug for the treatment of the cognitive impairment associated with schizophrenia and other mental disorders. The project, called “Spark”, has just received a 500,000 euro grant from the Ministry of Economy and Finance, through the 2014 “Retos-Colaboración” subprogram call as part of the National Programme for Research Aimed at the Challenges of Society’ (File. RTC-2014-1645-1).

 

Inveready enters biotech Agrasys after leading an increase of capital Blog Post

Inveready has invested 500,000 euros in the biotech Agrasys, based at the Parc Cientific de Barcelona, through its capital fund Inveready Invierte Biotech II.  With this contribution, the venture capital investment group has become owner of  a stake of the company, of which Uninvest, a management company, is also part of, after having joined the group in 2008, and which, on this occasion, has materialized its support -through its R & D  Unifondo fund-  entering the venture jointly with the development partners involved in the increase of capital.

 

Ken Morse, one of the world’s leading experts on entrepreneurship, will give a lecture at Parc Científic de Barcelona Blog Post

On 23 January, Kenneth Morse, an international leader in entrepreneurial training and accelerated business development, will give a conference at the Parc Cientifc de Barcelona (PCB) entitled Innovation Strategies for Ambitious Tech Companies‘. The event, organized by MeteosimAWS TruepowerESADE  and Parc Cientific de Barcelona, will address the different approaches and key players of innovation strategies and profitability of technology-based companies to achieve success and will give recommendations to drive strategic and global sales plans.